Rathika Chinniah, Murali Vijayan, Dhivakar Mani, Kamaraj Raju, Malini Ravi Padma, Ramgopal Sivanadham, Balakrishnan Karuppiah
Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai, India E-mail : immunobala@ mkuniversity.org.
Asian Pac J Cancer Prev. 2016;17(5):2491-7.
Human leukocyte antigen (HLA) genes have been implicated in cervical cancer in several populations.
To study the predispositions of HLA alleles/haplotypes with cervical cancer.
Clinically diagnosed and PAP smear confirmed cervical cancer patients (n 48) and age matched controls (n 47) were genotyped for HLA-A,-B,-DRB1* and DQB1* alleles by PCR-SSP methods.
The frequencies of alleles DRB104 (OR=2.57), DRB115 (OR=2.04), DQB10301 (OR=4.91), DQB10601 (OR=2.21), B15 (OR=13.03) and B07 (OR=6.23) were higher in cervical cancer patients than in the controls. The frequencies of alleles DRB110 (OR=0.22) and B35 (OR=0.19) were decreased. Strong disease associations were observed for haplotypes DRB115-DQB10601 (OR=6.56; < 3.5.10-4), DRB114-DQB10501 (OR=6.51; <0.039) and A11-B07 (OR=3.95; <0.005). The reduced frequencies of haplotypes DRB110-DQB10501 (OR=0.45), A03-B35 (OR=0.25) and A11-B35 (OR= 0.06) among patients suggested a protective association. HLA-C* typing of 8 patients who possessed a unique three locus haplotype 'A11-B07-DRB104' (8/48; 16.66%; OR=6.51; <0.039) revealed the presence of a four locus haplotype 'A11-B07-C01-DRB104' in patients (4/8; 50%). Amino acid variation analysis of susceptible allele DQB10601 suggested 'tyrosine' at positions β9 and β37 and tyrosine-non-tyrosine genotype combination increased the risk of cervical cancer.
Strong susceptible associations were documented for HLA alleles B15, B07, DRB104, DRB115, DQB10301, DQB10601 and haplotypes DRB115-DQB10601 and DRB114-DQB10501. Further, protective associations were evidenced for alleles B35 and DRB110 and haplotypes A11-B35 and DRB110-DQB10501 with cervical cancer in South India.
在多个群体中,人类白细胞抗原(HLA)基因与宫颈癌有关。
研究HLA等位基因/单倍型与宫颈癌的易感性。
采用聚合酶链反应-序列特异性引物(PCR-SSP)方法,对临床诊断并经巴氏涂片确诊的宫颈癌患者(n = 48)和年龄匹配的对照组(n = 47)进行HLA-A、-B、-DRB1和DQB1等位基因分型。
宫颈癌患者中,等位基因DRB104(比值比[OR]=2.57)、DRB115(OR=2.04)、DQB10301(OR=4.91)、DQB10601(OR=2.21)、B15(OR=13.03)和B07(OR=6.23)的频率高于对照组。等位基因DRB110(OR=0.22)和B35(OR=0.19)的频率降低。观察到单倍型DRB115-DQB10601(OR=6.56;<3.5×10⁻⁴)、DRB114-DQB10501(OR=6.51;<0.039)和A11-B07(OR=3.95;<0.005)与疾病有很强的关联。患者中单倍型DRB110-DQB10501(OR=0.45)、A03-B35(OR=0.25)和A11-B35(OR=0.06)频率降低,提示有保护关联。对8例拥有独特的三个基因座单倍型“A11-B07-DRB104”(8/48;16.66%;OR=6.51;<0.039)的患者进行HLA-C分型,发现患者中存在四个基因座单倍型“A11-B07-C01-DRB104”(4/8;50%)。对易感等位基因DQB1*0601的氨基酸变异分析表明,β9和β37位的“酪氨酸”以及酪氨酸-非酪氨酸基因型组合增加了患宫颈癌的风险。
记录到HLA等位基因B15、B07、DRB104、DRB115、DQB10301、DQB10601以及单倍型DRB115-DQB10601和DRB114-DQB10501与易感性有很强的关联。此外,在印度南部,等位基因B35和DRB110以及单倍型A11-B35和DRB110-DQB10501与宫颈癌存在保护关联。